Author(s):
Manisha P. Puranik, Debarshi Kar Mahapatra, Shital D. Tiple, Pornima G. Zade
Email(s):
manisha68_12@yahoo.com
DOI:
10.52711/0974-360X.2025.00778
Address:
Manisha P. Puranik1*, Debarshi Kar Mahapatra2, Shital D. Tiple1, Pornima G. Zade1
1Department of Quality Assurance, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha 442001, Maharashtra, India.
2Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 11,
Year - 2025
ABSTRACT:
The multiple sample analysis of Sacubitril (SAC) and Valsartan (VAL) in raw materials of drugs and tablets as pharmaceutical products was developed and validated through advanced thin-layer chromatographic procedures. This method was characterized to be efficient, reliable, repeatable, as well as being user-friendly. The target compounds were separated using aluminum sheets that had previously been coated with silica gel 60 F254 and uses a toluene, ethyl acetate, formic acid and triethylamine solvent mixture in order to accomplish its separation, where toluene was used in a triethylamine ratio of 7:3: 0.1:0.3 v/v/v/v respectively. The CAMAG LINOMAT V applicator was used to apply sample bands, the chromatograms scanned by means of the CAMAG TLC Scanner III. Collection and analysis of the data was processed with WinCATS software 1.4.3. SAC and VAL produced well-differentiated retention factor (Rf) values of 0.66 and 0.72, respectively. Throughout the analysis, methanol was used as the diluting medium. The developed method was validated following the ICH Q2(R1) standards, evaluating key parameters such as calibration curve linearity, recovery, reproducibility, and method consistency. Excellent correlation coefficients were observed, with r² values of 0.9977 for SAC and 0.9947 for VAL, confirming linear response within the tested range. Accuracy assessments via recovery at 50%, 100%, and 150% levels showed average retrieval rates of 99.03% for SAC and 100.74% for VAL. The repeatability of the technique, reflected by %RSD values, was found to be 0.716% for SAC and 0.465% for VAL. Further robustness testing through intra-day and inter-day variability studies yielded %RSD figures of 0.582 and 0.149 for SAC, and 0.466 and 0.416 for VAL, verifying the method's stability and dependability across different testing conditions.
Cite this article:
Manisha P. Puranik, Debarshi Kar Mahapatra, Shital D. Tiple, Pornima G. Zade. ICH-Compliant HPTLC Method for the Quantitative Determination of Sacubitril and Valsartan in Pharmaceutical Tablets. Research Journal Pharmacy and Technology. 2025;18(11):5395-0. doi: 10.52711/0974-360X.2025.00778
Cite(Electronic):
Manisha P. Puranik, Debarshi Kar Mahapatra, Shital D. Tiple, Pornima G. Zade. ICH-Compliant HPTLC Method for the Quantitative Determination of Sacubitril and Valsartan in Pharmaceutical Tablets. Research Journal Pharmacy and Technology. 2025;18(11):5395-0. doi: 10.52711/0974-360X.2025.00778 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-11-40
REFERENCES:
1. Dargad RR, Prajapati MR, Dargad RR, Parekh JD. Sacubitril/ valsartan: a novel angiotensin receptor-neprilysin inhibitor. Indian Heart J. 2018; 70: S102-10.
2. Singh JS, Burrell LM, Cherif M, Squire IB, Clark AL, Lang CC. Sacubitril/valsartan: beyond natriuretic peptides. Heart. 2017; 103(20): 1569-77.
3. Iborra-Egea O, Gálvez-Montón C, Roura S, Perea-Gil I, Prat-Vidal C, Soler-Botija C, Bayes-Genis A. Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach. NPJ Systems Biol. Appl. 2017; 3(1): 12.
4. Docherty KF, Vaduganathan M, Solomon SD, McMurray JJ. Sacubitril/valsartan: neprilysin inhibition 5 years after PARADIGM-HF. Heart Failure. 2020; 8(10): 800-10.
5. Malik AH, Aronow WS. Efficacy of sacubitril/valsartan in hypertension. Am. J. Ther. 2022; 29(3): e322-33.
6. Gökbulut A. High performance thin layer chromatography (HPTLC) for the investigation of medicinal plants. Curr. Anal. Chem. 2021; 17(9): 1252-9.
7. Ghogare JD, Panchal PP, Rathod SP, Jadhao UT. Stability Indicating HPTLC Method Development and Validation for Estimation of Nortriptyline and Pregabalin in Tablet Dosage Form. Asian J. Pharm. Anal. 2023; 13(1): 21-9.
8. Ghumare P, Dolas RT, Aher V. Development of HPTLC method for the estimation of andrgrapholide from Arjuna Tablet. Asian J. Pharm. Anal. 2021; 11(2): 156-8.
9. Puranik M, Mahapatra DK, Bhoyar HS. Stability-Indicating HPTLC Method for the Determination of Febuxostat in Bulk and Pharmaceutical Formulation. J. Med. Pharm. Allied Sci. 2022; 11(3): 4817-4823.
10. Dhiware TK, Patil PA, Salaraya MG. Development and validation of HPTLC method for determination of edoxaban in bulk and tablet. Asian J. Pharm. Anal. 2019; 9(3): 161-6.
11. Rajasekaran A, Arivukkarasu R, Linda M. Estimation of andrographolide content in aqueous extract of Siddha formulations by HPTLC. Asian J. Pharm. Anal. 2015; 5(4): 206-8.
12. Rode VP, Tajne MR. A Validated Stability-Indicating High-Performance Thin-Layer Chromatographic Method for the Analysis of Pitavastatin in Bulk Drug and Tablet Fomulation. Asian J. Pharm. Anal. 2018; 8(1): 49-52.
13. Tambe SR, Sawant SD. Determination of Terconazole from Biological Matrix by HPTLC and It's Characterization by MS. Asian J. Pharm. Anal. 2014; 4(3): 108-12.
14. Prajapati LM, Patel A, Patel JR, Joshi AK, Kharodiya M. High performance thin layer chromatography method for simultaneous estimation of cefepime hydrochloride and sulbactam sodium. Asian J. Pharm. Anal. 2016; 6(4): 207-12.
15. Jain V, Jain T, Saraf S, Saraf S. HPTLC method for routine quality control of Ayurvedic formulation Drakshadi gutika. Asian J. Pharm. Anal. 2013; 3(4): 111-4.
16. Patel M. Development and validation of simultaneous estimation of two catecholamines in combine dosage form by HPTLC Method. Asian J. Pharm. Anal. 2014; 4(2): 57-77.
17. Edlabadkar AP, Rajput AP. RP-HPTLC Method for Determination of Garenoxacin mesylate in Bulk and in Tablet Formulation. Asian J. Pharm. Anal. 2018; 8(2): 78-82.